by nikki mann | Nov 28, 2023 | News
We are delighted to announce a new partnership with AstraZeneca and the Medical Research Council (MRC) that will establish a new state-of-the-art functional genomics laboratory at the Milner Therapeutics Institute. This marks a significant step forward in our mission...
by nikki mann | Sep 20, 2023 | News
We are delighted to share that the Pathania Lab join a team of researchers who have been awarded £1.5 million in The Brain Tumour Charity’s Quest for Cures grant. Dr Manav Pathania and his group – who are based at the Milner Institute – join researchers from...
by nikki mann | Sep 11, 2023 | News
We are excited to announce that two new pharma partners — Takeda and Sanofi — have joined the Milner Consortium in the past month. Now with 14 pharma partners and 3 academic partners, this is the largest cross-sector Biomedical Consortia in the UK that is working in...
by nikki mann | Jul 10, 2023 | News
We were excited to welcome ∼500 delegates at West Road Concert Hall for our annual Symposium on July 5th, with a further 300+ UK and international delegates opting to view the talks online. A small selection of photographs can already be found on our website, with...
by nikki mann | May 19, 2023 | News
We are delighted that several of our affiliated companies were recognised at the 2023 Cambridge Independent Science & Technology Awards last night. Among the list of awardees was Cardiatec Biosciences, an AI drug target discovery company co-founded by Milner Head...
by nikki mann | Apr 3, 2023 | News
We are delighted to welcome Dr Cathy Tralau-Stewart as the new Executive Director at the Milner Therapeutics Institute. Cathy will work alongside Director Tony Kouzarides and the Milner team to lead and deliver our vision to transform pioneering science into...